Rosalind Watts
Clinical psychologist

Psilocybin For Depression: Introducing the ACE model (Accept, Connect, Embody)

This presentation introduces the new therapeutic approach used in the ongoing Psilocybin for Depression study (Psilodep 2) at Imperial College. The ACE model (Accept, Connect, Embody) seeks to support the inherent mechanisms of psychedelic therapy through the use of metaphor, therapeutic alliance, visualisation, somatic focusing, and narrative work. In this presentation, the mechanisms of Acceptance and Connection will be explored with reference to qualitative and quantitative research findings and clinical case examples from Psilodep 2. Some general reflections from the Psilodep2 team will also be shared, such as factors which may enhance or undermine the therapy.

Dr Rosalind Watts is the Clinical Lead of the Imperial College Psilocybin for Depression trial (Psilodep 2). She trained as a clinical psychologist at UCL and practised psychotherapy for 6 years before joining the Imperial Psychedelic Research Group, led by Robin Carhart-Harris. Rosalind designed the therapy protocol for Psilodep 2, works as a lead 'guide' alongside three other therapists, and is running the day-to-day aspects of the trial.

Her qualitative research, exploring the perspectives of participants in a number of psychedelic research studies, gave rise to her interest in the common theme of 'connectedness to Self, others, and the world' as an important aspect of psychedelic treatment. Rosalind co-hosts the monthly 'Psychedelic Integration Group' in London, alongside Michelle Baker Jones.

TEDx Oxford: